FDAs December 19 announcement ended a regulatory back and forth that I previously summarized here
Our licensed providers specialize in medical weight loss and will evaluate your health history, discuss your goals, and determine whether Zepbound, Wegovy, or another GLP-1 medication is right for you
The dosage starts low and increases gradually over several months to minimize side effects and allow the body to adjust to it
This extended duration of action is achieved through structural modifications that protect the molecule from rapid degradation and enhance binding to albumin in the bloodstream
EEs institution has received research funding from Novo Nordisk, Eli Lilly, AstraZeneca, Versanis, Endogenex, Novartis and Abbott for unrelated research